Becton, Dickinson and Co.

BDX

Becton, Dickinson and Co. (BDX) is a global medical technology company specializing in the development and manufacturing of medical devices, supplies, and laboratory equipment. Founded in 1897, it is known for its innovations in healthcare including syringes, safety-engineered devices, and diagnostic products, serving healthcare institutions, life sciences, and general medical markets worldwide.

$158.17 -1.76 (-1.10%)
Dividend Yield 2.65%
Payout Frequency Quarterly

Dividend History

Pay DateAmountEx-DateRecord Date
June 30, 2026$1.052026-06-092026-06-09
March 31, 2026$1.052026-03-102026-03-10
December 31, 2025$1.052025-12-082025-12-08
September 30, 2025$1.042025-09-082025-09-08
June 30, 2025$1.042025-06-092025-06-09

Dividends Summary

Company News

Eli Lilly and Novo Nordisk Are Fine -- but These 2 Stocks Could Be an Even Better Way to Invest in the GLP-1 Boom
The Motley Fool • Prosper Junior Bakiny • July 7, 2026

While Eli Lilly and Novo Nordisk are leaders in the GLP-1 market, Becton, Dickinson and Abbott Laboratories offer better indirect exposure to the GLP-1 boom. Becton, Dickinson supplies prefillable syringes with soaring demand and is a Dividend King, while Abbott's continuous glucose monitoring devices see increased adoption alongside GLP-1 medici...

Bloodstream Infection Testing Market Size to Reach USD 1,404.68 Million by 2035 | SNS Insider
GlobeNewswire Inc. • Sns Insider • June 26, 2026

The global bloodstream infection testing market is expected to grow at a CAGR of 4.80% through 2035, driven by rising sepsis cases, antimicrobial stewardship mandates, and adoption of rapid molecular diagnostics. North America leads the market, with the U.S. contributing 87.4% of regional revenues, while Asia Pacific shows the fastest growth. Key...

Enteric Disease Testing Market Worth USD 5.86 Billion by 2035 | SNS Insider
GlobeNewswire Inc. • Sns Insider • June 23, 2026

The global Enteric Disease Testing Market is valued at USD 4.08 billion in 2025 and is projected to reach USD 5.86 billion by 2035, growing at a CAGR of 3.70%. Growth is driven by increasing foodborne and waterborne disease prevalence, rising demand for rapid pathogen detection, and expanding adoption of multiplex molecular diagnostics. North Ame...

5 Dividend Stocks to Buy and Hold Forever
The Motley Fool • Justin Pope • June 22, 2026

The article highlights five blue-chip dividend stocks suitable for long-term buy-and-hold investing: AbbVie, McDonald's, Johnson & Johnson, Walmart, and Becton Dickinson. These companies have demonstrated decades of consecutive dividend increases and strong financial fundamentals, with dividends well-covered by earnings and solid growth prospects...

Wound Irrigation Systems Market to Skyrocket USD 430.05 Million by 2035 as Chronic Wound Cases and Surgical Volumes Rise Worldwide | SNS Insider
GlobeNewswire Inc. • Sns Insider • June 3, 2026

The global wound irrigation systems market is projected to grow from USD 307.87 million in 2025 to USD 430.05 million by 2035, with a CAGR of 3.55%. Growth is driven by rising chronic wound prevalence, increased surgical volumes, and innovations in pulsatile lavage systems. North America leads with 40% market share, while Asia Pacific shows the f...

Related Companies